Speciality Medicines IPO

Speciality Medicines Limited, incorporated in 2021, is engaged in the marketing and distribution of speciality pharmaceutical formulations. The company focuses on high-value oral and injectable medicines used to treat complex and chronic medical conditions. These medicines are supplied to both domestic and international markets. The company offers a diverse portfolio of finished pharmaceutical formulations available in multiple dosage forms such as tablets, capsules, creams, syrups, eye drops, gels, injections, inhalers, nasal sprays, ointments, infusions, oral solutions, sachets, suspensions, and ophthalmic solutions. This wide range allows the company to cater to different therapeutic needs and healthcare markets. Speciality Medicines operates through two main business models. The first is contract manufacturing of pharmaceutical formulations for international distribution, while the second involves marketing and distribution of sourced speciality pharmaceutical products.

The company has also expanded its international presence with products registered or under registration in countries such as Jordan, Ethiopia, Uganda, Peru, and Namibia. Its distribution network spans over 20 states in India and more than 35 countries globally. As of February 28, 2026, the company has 7 products registered internationally and 54 products under registration across 5 countries.